Breaking Finance News

Heska Corp (NASDAQ:HSKA) stock price target increased to $78.00, released a report earlier today by Benchmark

Reporting a possible upside of 0.19%, Benchmark increased the stock price target of Heska Corp (NASDAQ:HSKA) to $78.00

Previously on Monday November 28, 2016, Sidoti reported on Heska Corp (NASDAQ:HSKA) raised the target price from $0.00 to $71.00. At the time, this indicated a possible upside of 0.07%.

Yesterday Heska Corp (NASDAQ:HSKA) traded -1.09% lower at $65.60. Heska Corp’s 50-day average is $57.86 and its two hundred day average is $48.13. With the last stock price close up 36.31% relative to the two hundred day average, compared with the S&P 500 Index which has decreased -0.03% over the date range. Trading volume was down over the average, with 62,844 shares of HSKA changing hands under the typical 107,067

Recent Performance Chart

Heska Corp (NASDAQ:HSKA)

With a market capitalization of $0, Heska Corp has PE ratio of 52.52 with a one year low of $26.25 and a one year high of $69.80 .

A total of 4 firms have reported on the stock. 1 brokerage rating the stock a strong buy, 3 equity analysts rating the company a buy, zero equity analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the stock a sell with a consensus target price of $39.88.

About Heska Corp (NASDAQ:HSKA)

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals. It offers blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *